EUVIMEDEUVIMED entdecken
Crossref

Recruiting T‐Cells toward the Brain for Enhanced Glioblastoma Immunotherapeutic Efficacy by Co‐Delivery of Cytokines and Immune Checkpoint Antibodies with Macrophage‐Membrane‐Camouflaged Nanovesicles

Xiaoxuan Xu, Zhiqi Zhang, Jiawei Du, Yonger Xue, Xin Chen, Jianqiong Zhang, Xue Yang, Di Chang, Jinbing Xie, Shenghong Ju iD

Advanced Materials · 2023-06 · 35 (25)

DOI: 10.1002/adma.202209785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 04.05.2023. Verfasst von Xiaoxuan Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, 87 Din…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Key Research and Development Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy with immune checkpoint inhibitors (CPIs) shows promising prospects for glioblastoma multiforme (GBM) but with restricted results, mainly attributed to the immunosuppressive tumor microenvironment (TME) and the limited antibody permeability of the blood–tumor barrier (BTB) in GBM. Here, nanovesicles with a macrophage‐mimicking membrane are described, that co‐deliver chemotactic CXC chemokine ligand 10 (CXCL10), to pre‐activate the immune microenvironment, and anti‐programmed death ligand 1 antibody (aPD‐L1), to interrupt the immune checkpoint, aiming to enhance the effect of GBM immunotherapy. Consequently, the tumor tropism of the macrophage membrane and the receptor‐mediated transcytosis of the angiopep‐2 peptide allow the nanovesicle to effectively cross the BTB and target the GBM region, with 19.75‐fold higher accumulation of antibodies compared to the free aPD‐L1 group. The CPI therapeutic efficacy is greatly enhanced by CXCL10‐induced T‐cells recruitment with significant expansion of CD8 + T‐cells and effector memory T‐cells, leading to the elimination of tumor, prolonged survival time, and long‐term immune memory in orthotopic GBM mice. The nanovesicles, that relieve the tumor immunosuppressive microenvironment by CXCL10 to enhance aPD‐L1 efficacy, may present a promising strategy for brain‐tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsMiceAnimalsCD8-Positive T-LymphocytesCytokinesAntibodiesMacrophagesImmunotherapyBrainTumor Microenvironment

Stichwörter der Autor:innen

CXCL10blood-tumor barrierglioblastoma multiformeimmune checkpoint inhibitorsimmunosuppressive microenvironmentnanovesicles

Substanzen

CytokinesAntibodies

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, 87 DingJiaQiao Road, Nanjing, 210009, P. R. China.
  • Center for BioDelivery Sciences, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China.
  • Department of Microbiology and Immunology, Medical School, Southeast University, Nanjing, 210009, China.

ORCID-Profile: Shenghong Ju

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Key Research and Development Program of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Xu, X., Zhang, Z., Du, J., Xue, Y., Chen, X., Zhang, J., Yang, X., Chang, D., Xie, J., & Ju, S. (2023). Recruiting T‐Cells toward the Brain for Enhanced Glioblastoma Immunotherapeutic Efficacy by Co‐Delivery of Cytokines and Immune Checkpoint Antibodies with Macrophage‐Membrane‐Camouflaged Nanovesicles. Advanced Materials, 35(25). https://doi.org/10.1002/adma.202209785

Vancouver

Xu X, Zhang Z, Du J, Xue Y, Chen X, Zhang J, et al. Recruiting T‐Cells toward the Brain for Enhanced Glioblastoma Immunotherapeutic Efficacy by Co‐Delivery of Cytokines and Immune Checkpoint Antibodies with Macrophage‐Membrane‐Camouflaged Nanovesicles. Advanced Materials. 2023;35(25). doi:10.1002/adma.202209785

BibTeX
@article{Xu2023,
  author = {Xu, Xiaoxuan and Zhang, Zhiqi and Du, Jiawei and Xue, Yonger and Chen, Xin and Zhang, Jianqiong and Yang, Xue and Chang, Di and Xie, Jinbing and Ju, Shenghong},
  title = {Recruiting T‐Cells toward the Brain for Enhanced Glioblastoma Immunotherapeutic Efficacy by Co‐Delivery of Cytokines and Immune Checkpoint Antibodies with Macrophage‐Membrane‐Camouflaged Nanovesicles},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {25},
  doi = {10.1002/adma.202209785}
}
Kostenlos starten →